Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Page 1
Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer.
Im C, Neupane A, Baedke JL, Lenny B, Delaney A, Dixon SB, Chow EJ, Mostoufi-Moab S, Yang T, Richard MA, Gramatges MM, Lupo PJ, Sharafeldin N, Bhatia S, Armstrong GT, Hudson MM, Ness KK, Robison LL, Yasui Y, Wilson CL, Sapkota Y. Im C, et al. Among authors: chow ej. J Clin Oncol. 2024 Apr 23:JCO2302281. doi: 10.1200/JCO.23.02281. Online ahead of print. J Clin Oncol. 2024. PMID: 38652878
PURPOSE: Type 2 diabetes mellitus (T2D) is a prevalent long-term complication of treatment in survivors of childhood cancer, with marked racial/ethnic differences in burden. ...
PURPOSE: Type 2 diabetes mellitus (T2D) is a prevalent long-term complication of treatment in survivors of childhood cancer, with mar …
Effect of carvedilol versus placebo on cardiac function in anthracycline-exposed survivors of childhood cancer (PREVENT-HF): a randomised, controlled, phase 2b trial.
Armenian SH, Hudson MM, Lindenfeld L, Chen S, Chow EJ, Colan S, Collier W, Su X, Marcus E, Echevarria M, Iukuridze A, Robison LL, Wong FL, Chen MH, Bhatia S. Armenian SH, et al. Among authors: chow ej. Lancet Oncol. 2024 Feb;25(2):235-245. doi: 10.1016/S1470-2045(23)00637-X. Epub 2024 Jan 9. Lancet Oncol. 2024. PMID: 38215764 Clinical Trial.
BACKGROUND: Carvedilol improves cardiac function in patients with heart failure but remains untested as cardioprotective therapy in long-term childhood cancer survivors (ie, those who have completed treatment for childhood cancer and are in remission) at risk for heart fai …
BACKGROUND: Carvedilol improves cardiac function in patients with heart failure but remains untested as cardioprotective therapy in long- …
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy.
Leger KJ, Robison N, Narayan HK, Smith AM, Tsega T, Chung J, Daniels A, Chen Z, Englefield V, Demissei BG, Lefebvre B, Morrow G, Dizon I, Gerbing RB, Pabari R, Getz KD, Aplenc R, Pollard JA, Chow EJ, Tang WHW, Border WL, Sachdeva R, Alonzo TA, Kolb EA, Cooper TM, Ky B. Leger KJ, et al. Among authors: chow ej. Front Cardiovasc Med. 2023 Dec 1;10:1286241. doi: 10.3389/fcvm.2023.1286241. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38107263 Free PMC article.
BACKGROUND: Pediatric acute myeloid leukemia (AML) therapy is associated with substantial short- and long-term treatment-related cardiotoxicity mainly due to high-dose anthracycline exposure. ...Together, these measures have the potential to improve leukemia-free and overa …
BACKGROUND: Pediatric acute myeloid leukemia (AML) therapy is associated with substantial short- and long-term treatment-related card …
Association analysis of self-reported outcomes with a validated subset.
Mirzaei S, Martínez JM, Chow EJ, Ness KK, Hudson MM, Armstrong GT, Yasui Y. Mirzaei S, et al. Among authors: chow ej. Stat Med. 2024 Feb 20;43(4):642-655. doi: 10.1002/sim.9976. Epub 2023 Dec 13. Stat Med. 2024. PMID: 38088465
This methodological work was motivated by a large cohort study of long-term childhood cancer survivors, allowing us to provide a relevant application example where we examined the association between clinical factors and chronic health conditions....
This methodological work was motivated by a large cohort study of long-term childhood cancer survivors, allowing us to provide a rele …
Development and validation of age-specific risk prediction models for primary ovarian insufficiency in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study and St Jude Lifetime Cohort.
Im C, Lu Z, Mostoufi-Moab S, Delaney A, Yu L, Baedke JL, Han Y, Sapkota Y, Yasui Y, Chow EJ, Howell RM, Bhatia S, Hudson MM, Ness KK, Armstrong GT, Nathan PC, Yuan Y. Im C, et al. Among authors: chow ej. Lancet Oncol. 2023 Dec;24(12):1434-1442. doi: 10.1016/S1470-2045(23)00510-7. Epub 2023 Nov 14. Lancet Oncol. 2023. PMID: 37972608
We aimed to develop and validate models to predict age-specific POI risk among long-term survivors of childhood cancer. METHODS: To develop models to predict age-specific POI risk for the ages of 21-40 years, we used data from the Childhood Cancer Survivor Study (CCSS). .. …
We aimed to develop and validate models to predict age-specific POI risk among long-term survivors of childhood cancer. METHODS: To d …
Impact of Hematopoietic Cell Transplantation on Cardiovascular Risk Factors and Insulin Sensitivity.
Ketterl TG, Chow EJ, Koves IH, Goodman P, Leisenring WM, Ballard S, Dengel DR, Moran A, Sinaiko AR, Steinberger J, Baker KS. Ketterl TG, et al. Among authors: chow ej. Transplant Cell Ther. 2024 Feb;30(2):243.e1-243.e13. doi: 10.1016/j.jtct.2023.10.026. Epub 2023 Nov 5. Transplant Cell Ther. 2024. PMID: 37935316
The use of hematopoietic cell transplantation (HCT) for treating malignant conditions in children has increased over the past five decades, leading to a growing population of long-term survivors.This population of childhood HCT survivors faces increased risks of adverse me …
The use of hematopoietic cell transplantation (HCT) for treating malignant conditions in children has increased over the past five decades, …
Financial Hardship in Childhood Cancer Survivors Treated with Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study.
Buchbinder D, Bhatt NS, Wang H, Yasui Y, Armenian S, Bhatia S, Chow EJ, Huang IC, Kirchoff AC, Leisenring W, Park ER, Yabroff KR, Armstrong GT, Nathan PC, Khera N. Buchbinder D, et al. Among authors: chow ej. Transplant Cell Ther. 2023 Nov;29(11):705.e1-705.e9. doi: 10.1016/j.jtct.2023.07.024. Epub 2023 Aug 2. Transplant Cell Ther. 2023. PMID: 37541329
Long-term survivors of childhood cancer are at risk for financial hardship. ...
Long-term survivors of childhood cancer are at risk for financial hardship. ...
Late-onset Cognitive Impairment and Modifiable Risk Factors in Adult Childhood Cancer Survivors.
Phillips NS, Stratton KL, Williams AM, Ahles T, Ness KK, Cohen HJ, Edelstein K, Yasui Y, Oeffinger K, Chow EJ, Howell RM, Robison LL, Armstrong GT, Leisenring WM, Krull KR. Phillips NS, et al. Among authors: chow ej. JAMA Netw Open. 2023 May 1;6(5):e2316077. doi: 10.1001/jamanetworkopen.2023.16077. JAMA Netw Open. 2023. PMID: 37256617 Free PMC article.
IMPORTANCE: Long-term survivors of childhood cancer may be at elevated risk for new neurocognitive impairment and decline as they age into adulthood. ...
IMPORTANCE: Long-term survivors of childhood cancer may be at elevated risk for new neurocognitive impairment and decline as they age …
Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer.
Wu NL, Chen Y, Dieffenbach BV, Ehrhardt MJ, Hingorani S, Howell RM, Jefferies JL, Mulrooney DA, Oeffinger KC, Robison LL, Weil BR, Yuan Y, Yasui Y, Hudson MM, Leisenring WM, Armstrong GT, Chow EJ. Wu NL, et al. Among authors: chow ej. J Clin Oncol. 2023 Apr 20;41(12):2258-2268. doi: 10.1200/JCO.22.01926. Epub 2023 Feb 16. J Clin Oncol. 2023. PMID: 36795981 Free PMC article.
52 results